“Chemotherapy and radiotherapy have been used for many years to fight cancer, but the success of these treatments is low at best. Research studies have discovered possible natural alternatives that may help find a cancer cure.”
July 23, 2019
Helping people beat and cure cancer has always been the driving force behind Dr. Mirko Beljanski & The Beljanski Foundation’s research. This research reveals that natural molecules can selectively target cancer cells and work alongside many chemotherapy drugs. Winning The War On Cancer: The Epic Journey Towards a Natural Cure tells my story, the quest to carry on my father Dr. Mirko Beljanski’s legacy and to discover a new treatment for cancer. The book combines scientific information with a tale of defiance, hope, despair, personal growth & love. Stayed tuned for dates of the upcoming Book Signing Tour this Fall!
March 26, 2019
Winning the War on Cancer: Sylvie Beljanski’s fight to affirm her father’s legacy and offer a possible alternative cure. Winning the War on Cancer is the new book by award nominated writer Sylvie Banjanski telling the gripping tale of her father Mirko Beljanski, a devoted physician who discovered a natural cancer reducing remedy. His findings, being a threat to many insurance companies caused a political altercation, causing the French government to promptly shut down his research laboratory and saw him imprisoned. The first 24 hours after his arrest he was forced to spend the night in his lab, where dangerous chemicals were sprayed by the government, leading him to his death shortly after.
December 28, 2018
Cancer tumors are made up of different types of cells. The primary tumor is made up of “regular cancer cells”, once healthy cells whose cell growth regulation gene were altered and damaged by toxins. This alteration causes the unregulated division of cell growth which forms into a tumor. The other type of cell in a tumor are cancer stem cells. Much like regular stem cells, cancer stem cells are capable of resisting treatments and proliferating from the original tumor to metastasize in other parts of the body. Chemotherapy and other available treatments target the primary tumor; however, the cancer stem cells can remain and eventually cause a relapse. Once the cancer metastizes, it is incredibly difficult to treat due to its increased resistance. Metastatic cancer is responsible for 90% of cancer patient deaths, a statistic which has not improved for over fifty years. Stem Cells and Cancer Stem Cells Current cancer treatments such as chemotherapy and radiotherapy are capable of killing cancer tumors, but that only leads to remission. None of the current treatments available can effectively kill cancer stem cells, which is what causes the relapse. While these treatments may be able to kill a relapsed tumor, the remission […]
December 28, 2018
The evolution of oncology treatments can be attributed to the extensive research and data compilation from clinical trials. These research studies are used to determine newer and more effective ways to treat cancer. They expand treatment options for all cancer patients. The more people participate, the faster the research can become legitimized as anti-cancer therapies. Clinical trials provide patients with new and emerging therapies which may actually be better than current cancer treatments. It offers patients the chance to help others by improving treatments for other cancer patients. According to data, the implementation of clinical trials has an overall benefit of increasing the survival rate of cancer patients. However, there are only about 5% of cancer patients that actually participate, particularly within the demographic of adolescents and young adults. What Are Clinical Trials? A clinical trial takes two groups of patients and divides them into two groups. One is an experimental group and the other is the control group. The group that has been selected for the experiment will receive the new drug while the control group is given standard treatment. Researchers then compare the two groups depending on specific criteria, such as how well the cancer is affected and […]